Listening to Your Compliance Challenges. Delivering Creative Solutions.

Create an Account

Exceeding expectations one customer at a time

Edge Pharma is an FDA registered 503B Outsourcing Facility offering high quality innovative solutions for the healthcare community. The world-class scientific, pharmacy, and engineering staff at Edge Pharma understands the challenges healthcare organizations, whether large or small, are tackling. As your compliance partner, we are dedicated to providing turnkey 503B outsourcing with the highest level of quality, easy ordering, simple logistics, and excellent customer support.

Contact Us

856 Hercules Drive,
Colchester, VT 05446

Phone: 802-992-1178
Fax: 802-489-6300

Contact Us

Careers at Edge

We are growing and looking for talented people.

Visit Careers Page



Edge Product Highlight

  • MVASITM Bevacizumab: Edge Pharma offers repackaged MVASI™ (bevacizumab-awwb) in unit-dose silicone free syringes. No vial drop-shipping means both device compliance and convenience.
  • LET Gel: Unit-dose syringes of compounded LET Gel for hospital emergency departments, urgent care centers, pediatrician offices, and other qualified health care providers. LET Gel is a topical anesthetic consisting of Lidocaine, Epinephrine, and Tetracaine.
  • Gemcitabine Bladder Instillation Kitcompounded Gemcitabine Bladder Instillation Syringe kits with a 1g / 50mL pre-filled unit-dose syringe of Gemcitabine, a closed system transfer device (CSTD), and catheter tip.
  • Methacholine Challenge Test Kit: Prefilled, color coded, and barcoded unit dose syringes are simple and convenient to use.


Haiti Mission Strives to Prevent Blindness

Here at Edge Pharma, we were very pleased to learn of the success of the most recent Haiti Eye Mission trip to Pignon, Haiti. Edge donates ophthalmic medications for this great cause. Led by Dr. Lance Bergstrom of Fargo, ND, this year’s team provided 1,400 eye exams and 335 surgeries, all in one week in May. Hundreds of eyeglasses were distributed, and $2 million worth of glaucoma drops dispensed. Glaucoma affects 25% of the population in Haiti.

Pignon is one of the most impoverished communities in the island nation, and healthcare access is an ongoing challenge, says Kristin Follman, director of the nonprofit organization. Some patients walk miles and sleep outside the clinic, waiting their turn to be seen. No one is turned away.

Here are a few of this year’s success stories, shared in the Haiti Eye Mission newsletter:

  • An 11-year-old boy who was blind with cataracts, can now see and go to school for the first time in his life
  • A young woman with special needs can see for the first time in 17 years and now can feed herself and walk without assistance
  • A young father and his two teenage sons were diagnosed with glaucoma early and received a year’s worth of sight-saving glaucoma drops

To learn more, visit https://www.haitieyemission.com/

   Haiti eye mission Kristin 500

 

myopia and covid 19 225px

Myopia Another Ramification of COVID-19

. The American Academy of Pediatrics reports that the increased time children spent indoors over the last year, as well as increased time spent looking at “near targets,” such as computer screens, has led to a higher incidence of myopia among children...   [continue]

 

dentist checkup 225

Back-to-School Dental Checkup

The American Dental Association urges parents to make the back-to-school dental checkup as early as possible, as the late August rush may make it hard to get in...   [continue]

 

Edge Pharma Announces New Agreement with Cardinal Health’s Acuity™ GPO

Edge Pharma, a 503B Outsourcing Facility, has entered into an agreement with Cardinal Health’s Acuity™ GPO to provide its member ophthalmology practices with Edge’s unit-dose MVASI™ (Bevacizumab-awwb) syringes and additional retina products....   [continue]

 

Stress Related Dental Issues 225

Increase in Stress-Related Dental Issues

U.S. dentists saw a marked increase in stress-related oral health conditions since the onset of the COVID-19 pandemic, according to a poll conducted the Health Policy Institute...   [continue]

 

eyelid skin cancer post 225

Let Gel and Eyelid Skin Cancer

Ultraviolet light is damaging not only to the eyes, but to the “thinnest and most sensitive skin on the body,” – the eyelid. Between 5 and 10% of all skin cancers are found on the eyelid. Approximately 90% of eyelid skin cancers are basal cell carcinomas...   [continue]

 

Read More News ...